ARBs offer new avenue for treating aortic stenosis
Angiotensin-receptor blockers (ARBs) may be an effective treatment in calcific aortic stenosis (AS), potentially reducing the risk of mortality in people with the condition by 30% over an eight-year period, according to early findings presented at this year’s Canadian Cardiovascular Congress